Page last updated: 2024-08-21

fluorobenzenes and Renal Insufficiency

fluorobenzenes has been researched along with Renal Insufficiency in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albertson, TE; Bernard, GR; Brower, RG; deBoisblanc, BP; Douglas, IS; Hite, RD; Hough, CL; Liu, KD; Matthay, MA; Rock, P; Shanholtz, C; Steingrub, J; Thompson, BT; Truwit, JD1
Burger, DM; de Kanter, CT; Keuter, M; Koopmans, PP; van der Lee, MJ1
Anzalone, D; Cain, VA; Cressman, MD; Shepherd, J; Stein, EA; Vidt, DG1
Chen, PZ; Feng, Y; Kang, L; Liu, M; Liu, YZ; Wang, ZF; Zhang, YM; Zheng, JH1
Ault, A1
Wolfe, SM1
Alsheikh-Ali, AA; Ambrose, MS; Karas, RH; Kuvin, JT1

Reviews

1 review(s) available for fluorobenzenes and Renal Insufficiency

ArticleYear
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.
    Atherosclerosis, 2012, Volume: 221, Issue:2

    Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol, LDL; Clinical Trials as Topic; Evidence-Based Medicine; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors

2012

Trials

1 trial(s) available for fluorobenzenes and Renal Insufficiency

ArticleYear
Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
    The New England journal of medicine, 2014, Jun-05, Volume: 370, Issue:23

    Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Female; Fluorobenzenes; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Sulfonamides; Survival Analysis; Treatment Failure

2014

Other Studies

5 other study(ies) available for fluorobenzenes and Renal Insufficiency

ArticleYear
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.
    Antiviral therapy, 2011, Volume: 16, Issue:3

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Dyslipidemias; Fluorobenzenes; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lopinavir; Male; Middle Aged; Pyrimidines; Pyrimidinones; Renal Insufficiency; Rhabdomyolysis; Ritonavir; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2011
Protective effects of rosuvastatin in experimental renal failure rats via improved endothelial function.
    Biological research for nursing, 2013, Volume: 15, Issue:3

    Topics: Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides

2013
Pressure group urges rosuvastatin recall.
    Lancet (London, England), 2004, Mar-13, Volume: 363, Issue:9412

    Topics: Adult; Advisory Committees; Drug and Narcotic Control; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration

2004
Dangers of rosuvastatin identified before and after FDA approval.
    Lancet (London, England), 2004, Jun-26, Volume: 363, Issue:9427

    Topics: Drug Approval; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pyrimidines; Renal Insufficiency; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration

2004
The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.
    Circulation, 2005, Jun-14, Volume: 111, Issue:23

    Topics: Consumer Product Safety; Drug Evaluation; Drug Prescriptions; Fluorobenzenes; Humans; Kidney Diseases; Morbidity; Product Surveillance, Postmarketing; Proteinuria; Pyridines; Pyrimidines; Renal Insufficiency; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides

2005